HaplnScience
Seongnam
About HaplnScience
HaplnScience is a pharmaceutical company that focuses on anti-aging therapies that can reverse tissue and organ degeneration. The company contributes to the health and happiness of the elderly through the development of anti-aging therapy that can reverse tissue and organ degeneration. They developing new medicines with HAPLN1, a new protein that can reverse tissue degeneration with strengthening the extracellular matrix. HalpnScience was founded in 2018 and is headquartered in Seongnam-si, Gyeonggi-do, South Korea.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Dec 2020)
- Website: haplnscience.com
- Phone: 031-724-2611
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/haplnscience-2653129 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.